Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Int J Cancer
    November 2026
  1. VAN DER ZIJDEN CJ, Huizer TJ, Eyck BM, van der Gaast A, et al
    Total Neoadjuvant Treatment for Esophageal Adenocarcinoma With Oligometastases: TNT-OES-1 Trial.
    Int J Cancer. 2026;159:2552-2561.
    >> Share

    October 2026
  2. ABLINGER C, Huber-Cantonati P, Weber DD, Pichler S, et al
    Combination of Lenvatinib and Antibiotics: A Potential Approach to Enhance Sensitivity in Differentiated Thyroid Cancer.
    Int J Cancer. 2026;159:1974-1989.
    >> Share

  3. ZHAO X, Wen S, Song C, Wang J, et al
    Optimal Sequencing of First-Line Immune Checkpoint Inhibitors With Definitive Chemoradiotherapy: A Multicenter Real-World Cohort Study Comparing Induction, Concurrent, and Consolidation Strategies for Unresectable Locally Advanced Esophageal Squamous
    Int J Cancer. 2026 Oct 6. doi: 10.1002/ijc.70740.
    >> Share

  4. LIU Q, Zeng ZM, Kuang YW, Hua YC, et al
    Systemic Inflammation Mediates the Association Between Plasma Epstein-Barr Virus DNA and Mortality in Metastatic Nasopharyngeal Carcinoma.
    Int J Cancer. 2026 Oct 5. doi: 10.1002/ijc.70772.
    >> Share

  5. HILLE J, Lorenzen S, Pauligk C, Gensch V, et al
    Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial.
    Int J Cancer. 2026;159:1817-1828.
    >> Share

    September 2026
  6. SHI X, Xu W, Wu Y, Yang Y, et al
    Heterogeneity in Postoperative Survival Benefit Associated With Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma: A Causal Survival Forest Analysis.
    Int J Cancer. 2026 Sep 15. doi: 10.1002/ijc.70729.
    >> Share

  7. XIE RL, Zou YH, Chen ZX, Zhang LL, et al
    Comparative Effectiveness of Induction Chemotherapy Regimens in Pediatric and Adolescent Locally Advanced Nasopharyngeal Carcinoma: A Retrospective IPTW Analysis.
    Int J Cancer. 2026 Sep 10. doi: 10.1002/ijc.70724.
    >> Share

  8. CHENG HS, Yacoub I, Wong W, Dunn LA, et al
    Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma.
    Int J Cancer. 2026 Sep 7. doi: 10.1002/ijc.70723.
    >> Share

  9. BONET C, Rizzolo-Brime L, Montanes S, Hajji M, et al
    Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition (EPIC) Study.
    Int J Cancer. 2026;159:1176-1187.
    >> Share

  10. MUNN K, Lawrence R, Haboubi H, Naser H, et al
    Lymphocyte Micronucleus Formation Is Driven by Inflammation-Induced Oxidative DNA Damage in Oesophageal Cancer Development.
    Int J Cancer. 2026;159:1311-1321.
    >> Share

  11. DUYMAZ MC, Ozkaya Duymaz E, Unsal N, Bekis R, et al
    Pretreatment EBV-DNA/TLG-Based Risk Stratification Is Associated With Survival Outcomes in Nonmetastatic Nasopharyngeal Carcinoma: An Exploratory Study.
    Int J Cancer. 2026 Sep 1. doi: 10.1002/ijc.70732.
    >> Share

    August 2026
  12. ZHU X, Zhang X, Liu J, Li Z, et al
    Clinical Value of Patient-Derived Tumor Organoids in Guiding Precision Chemotherapy for Locally Advanced Thyroid Cancer: A Single-Center, Single-Arm, Phase 2 Trial.
    Int J Cancer. 2026;159:836-843.
    >> Share

  13. QUAAS A, Schiemann H, Lyu SI, Zander T, et al
    Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.
    Int J Cancer. 2026 Aug 12. doi: 10.1002/ijc.70687.
    >> Share

    July 2026
  14. FANG Y, Yi C, Sun R, Shen B, et al
    Global Annualized Recurrence Rates and Dynamic Risk Profiles in Head and Neck Cancer.
    Int J Cancer. 2026 Jul 26. doi: 10.1002/ijc.70675.
    >> Share

  15. GAI X, Huang S, Ye J, Zeng J, et al
    Effects of Hippocampal Avoidance on Anxiety in Patients With Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy: A Single-Center, Single-Arm, Prospective Clinical Trial.
    Int J Cancer. 2026 Jul 26. doi: 10.1002/ijc.70631.
    >> Share

  16. GROTHEY B, Loser H, Bedau T, Schroder W, et al
    Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro-inflammatory tumor microenvironment in esophageal adenocarcinoma.
    Int J Cancer. 2026;159:501-515.
    >> Share

  17. PULLAT GB, Bohrmann B, George GS, Dikshit S, et al
    The impact of tobacco cessation on buccal mucosa cancer risk: A multi-centre case-control study in India.
    Int J Cancer. 2026;159:368-377.
    >> Share

  18. XING S, Shi S, Jin M, Han L, et al
    Pembrolizumab-Chemotherapy Versus Pembrolizumab in Head and Neck Squamous Cell Carcinoma: A PD-L1 CPS-Stratified Analysis of Updated KEYNOTE-048 Data.
    Int J Cancer. 2026 Jul 11. doi: 10.1002/ijc.70649.
    >> Share

    June 2026
  19. PENNY L, Stutheit-Zhao EY, Michels BE, Rosing F, et al
    HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.
    Int J Cancer. 2026 Jun 30. doi: 10.1002/ijc.70619.
    >> Share

  20. FELDMANN N, Wichmann G, Dietz A, Pirlich M, et al
    Cohort study of standardized treatment pathways by multidisciplinary tumor board decision making in patients with salivary gland malignancies.
    Int J Cancer. 2026;158:3241-3251.
    >> Share

    May 2026
  21. LIN G, Ge F, Liu Y, Men Y, et al
    Optimal Neoadjuvant Approach for Resectable Esophageal Cancer in the Era of Immunotherapy.
    Int J Cancer. 2026 May 20. doi: 10.1002/ijc.70521.
    >> Share

  22. MASETTI M, Petrelli F, Pietrantonio F, Lorenzen S, et al
    Immunotherapy in advanced gastroesophageal cancers: A meta-analysis of sex-based outcomes in overall survival.
    Int J Cancer. 2026;158:2697-2708.
    >> Share

  23. XIA X, Yan J, Xu L, Sun X, et al
    Nimotuzumab Combined With Concurrent Curative Radiotherapy and S-1 in 75 Years and Older Patients With Stage II-IVB Esophageal Squamous Cell Carcinoma: A Phase II Study.
    Int J Cancer. 2026 May 13. doi: 10.1002/ijc.70550.
    >> Share

  24. HUANG S, Han YQ, Yang KY, Qu S, et al
    Penpulimab and Gemcitabine With or Without Anlotinib in Metastatic Nasopharyngeal Carcinoma: A Randomized, Open-Label, Multicenter Phase 2 Study.
    Int J Cancer. 2026 May 7. doi: 10.1002/ijc.70542.
    >> Share

  25. WEI C, Wei H, Chen X, Zheng Z, et al
    Patterns of recurrence after curative resection and adjuvant chemotherapy in gastric and gastroesophageal junction cancer.
    Int J Cancer. 2026;158:2240-2252.
    >> Share

    April 2026
  26. DE ABREU M, Kowalski LP, Lopez RM, Barul C, et al
    Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium.
    Int J Cancer. 2026 Apr 21. doi: 10.1002/ijc.70497.
    >> Share

  27. MARINHO MFP, da Fonseca Simas KB, Heras PV, da Cruz CAS, et al
    Effectiveness of Organized Strategies to Enhance Access to Preventive Oral Cancer Screening Among High-Risk Individuals in Brazil: A Randomized Clinical Trial in Primary Care.
    Int J Cancer. 2026 Apr 21. doi: 10.1002/ijc.70511.
    >> Share

  28. JOSEPH G, van Gerwen M, Kim-Schulze S, Chen Z, et al
    Inflammatory proteins in pre-diagnosis versus at-diagnosis samples associated with differentiated thyroid cancer.
    Int J Cancer. 2026;158:2072-2082.
    >> Share

  29. WEGGE M, Dok R, Dubois LJ, Nuyts S, et al
    Hypoxia Induces a Mitotic Survival Advantage After Radiotherapy in Head and Neck Cancer Cells.
    Int J Cancer. 2026 Apr 13. doi: 10.1002/ijc.70479.
    >> Share

  30. BEAUSSIRE-TROUVAY L, Obongo-Anga FR, Leveque E, Berghian A, et al
    Peri-Operative Detection of Circulating Tumor DNA Using a Customized NGS Tumor-Informed Assay in Patients With HPV-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Int J Cancer. 2026 Apr 10. doi: 10.1002/ijc.70478.
    >> Share

  31. JAKOBSEN KK, Rehman U, Gronhoj C, Lau ZJ, et al
    Awareness of Human Papillomavirus (HPV), Increasing Rates of Oropharyngeal Cancer, and Estimated Economic Burden in Denmark.
    Int J Cancer. 2026 Apr 7. doi: 10.1002/ijc.70477.
    >> Share

    March 2026
  32. LIU Y, Li B, Wang Z, Zheng S, et al
    Impact of lymphatic ablation approaches on immunotherapy efficacy in advanced/metastatic esophageal squamous cell carcinoma: A multi-institutional retrospective cohort study.
    Int J Cancer. 2026 Mar 23. doi: 10.1002/ijc.70459.
    >> Share

  33. LI R, Shayan G, Zhao Y, Zhang S, et al
    Trends and epidemiology of human papillomavirus-related oropharyngeal cancer in Chinese populations from 2010 to 2024.
    Int J Cancer. 2026;158:1564-1576.
    >> Share

  34. YAKSICH L, Hartel G, Panizza BJ, Whiteman DC, et al
    Prevalence and distribution of HPV types in Australian patients with oropharyngeal cancer over time.
    Int J Cancer. 2026 Mar 7. doi: 10.1002/ijc.70432.
    >> Share

  35. ZHANG M, Xie D, Hu Y, Qin G, et al
    Overdiagnosis of thyroid cancer in the United States: Improved estimates based on the SEER registries during 2000-2019.
    Int J Cancer. 2026;158:1215-1226.
    >> Share

    February 2026
  36. NETHAN ST, Perez-de-Oliveira ME, Campbell F, Santos-Silva AR, et al
    Interventions for oral cancer prevention: An evidence and gap map.
    Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70391.
    >> Share

  37. WU H, Li Y, Ran L, Xia Z, et al
    Needle-shaped diatom frustules in food as a possible promoter of esophageal squamous cell carcinoma in coastal southeastern China: A pilot study.
    Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70394.
    >> Share

  38. PENG L, Ding X, Zou RC, You R, et al
    Comparison of >/=2 lines immunotherapy regimens for recurrent/metastatic nasopharyngeal carcinoma.
    Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70399.
    >> Share

  39. CUI Z, Zhao Y, Xu Q, Zhao R, et al
    Multilevel pathways to esophageal cancer: Population attributable risks of modifiable exposures, surrogate blood biomarkers, and genetic susceptibility, and the mediation effects based on a 10-year prospective cohort study.
    Int J Cancer. 2026 Feb 16. doi: 10.1002/ijc.70383.
    >> Share

  40. OUYANG YF, Liang JL, Xie RQ, Liu YP, et al
    The value of nasopharyngeal brush versus plasma EBV DNA detection in diagnosing local recurrence of nasopharyngeal carcinoma.
    Int J Cancer. 2026 Feb 3. doi: 10.1002/ijc.70357.
    >> Share

  41. PEREZ-LEAL M, Estornut C, Alfaro-Ochoa L, Sanchez-Herrera G, et al
    Cigarette smoke induces expression of senescence markers and pro-inflammatory SASP in oral mucosa: Potential implications for early carcinogenic processes.
    Int J Cancer. 2026;158:752-762.
    >> Share

    December 2025
  42. TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
    Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
    Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
    >> Share

  43. HADJI M, Rashidian H, Marzban M, Rezaianzadeh A, et al
    The association between waterpipe smoking and head and neck squamous cell carcinoma: A multicenter case-control study in Iran.
    Int J Cancer. 2025 Dec 26. doi: 10.1002/ijc.70258.
    >> Share

  44. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Reply to 'Comment on "Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis"'.
    Int J Cancer. 2025 Dec 18. doi: 10.1002/ijc.70292.
    >> Share

  45. MISRA SR, Das R
    Comments on "Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors".
    Int J Cancer. 2025 Dec 17. doi: 10.1002/ijc.70303.
    >> Share

  46. KRAEMER M, Wirsik NM, Alakus H, Schloesser HA, et al
    Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapy.
    Int J Cancer. 2025;157:2558-2568.
    >> Share

  47. SOMAY E, Bascil S, Topkan E, Selek U, et al
    Comment on "Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis".
    Int J Cancer. 2025 Dec 15. doi: 10.1002/ijc.70290.
    >> Share

  48. IMLIMTHAN S, Bahrami K, Pehkonen H, Centanni A, et al
    Biological evaluation of a glucose-based boron carrier as a potential agent for boron neutron capture therapy.
    Int J Cancer. 2025;157:2374-2384.
    >> Share

    November 2025
  49. DOEVE BH, Kuijper SC, Silversmit G, van Walle L, et al
    Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparison.
    Int J Cancer. 2025 Nov 19. doi: 10.1002/ijc.70225.
    >> Share

  50. WANG Y, Xi Y, Qiao L, Yu Y, et al
    Ethnic, sex, and age disparities in esophageal cancer and medical costs: A population-based study of 18 million people in China.
    Int J Cancer. 2025 Nov 11. doi: 10.1002/ijc.70236.
    >> Share

    October 2025
  51. JIANG KY, Hu WL, Liu SX, Wang L, et al
    Efficacy of adjuvant immunotherapy and immunochemotherapy in esophageal squamous cell carcinoma: A retrospective cohort study.
    Int J Cancer. 2025 Oct 28. doi: 10.1002/ijc.70214.
    >> Share

  52. NASMAN T, Birgersson M, Marklund L, Nasman A, et al
    Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC).
    Int J Cancer. 2025 Oct 23. doi: 10.1002/ijc.70207.
    >> Share

  53. SU Q, Feng R, Du S, Zhao H, et al
    Urinary mycotoxins and esophageal cancer risk in China: A case-cohort study.
    Int J Cancer. 2025 Oct 20. doi: 10.1002/ijc.70206.
    >> Share

  54. HAN W, Gao L, Wang X, Li C, et al
    Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.
    Int J Cancer. 2025 Oct 15. doi: 10.1002/ijc.70176.
    >> Share

    September 2025
  55. VERHOEVEN RHA, Kuijper SC, Slingerland M, Wijnhoven B, et al
    Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.
    Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70168.
    >> Share

  56. OSWAL K, Barman S, Kerr AR, Zaman M, et al
    Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India.
    Int J Cancer. 2025 Sep 19. doi: 10.1002/ijc.70160.
    >> Share

  57. VAN DER VEN RGFM, van Erning FN, Westra DD, de Hingh IHJT, et al
    Nationwide trends and the impact of an oncology hospital network on reducing the burden of thyroid cytology procedures.
    Int J Cancer. 2025;157:1120-1129.
    >> Share

  58. AMURE MT, Madathil SA, Laprise C, Rousseau MC, et al
    Oral co-infection with multiple alpha-human papillomavirus and head and neck cancer risk.
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70124.
    >> Share

  59. DENNIS CD, Cohen DJ, Debnath K, Schwartz N, et al
    24R,25(OH)(2)D(3) regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane-associated receptor complexes in ER+ and ER- cells.
    Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70141.
    >> Share

    August 2025
  60. LI ZZ, Wei LY, Cao LM, Wang GR, et al
    Neck management in cT1-2N0 oral squamous cell carcinoma: Act or watchful wait?
    Int J Cancer. 2025;157:614-626.
    >> Share

  61. MA S, Zhang Y, Xie S, Li X, et al
    Balanced diet quality and risk of upper gastrointestinal cancers: Insights from a prospective cohort study in China.
    Int J Cancer. 2025;157:658-671.
    >> Share

  62. NASMAN A, Birgersson M, Nasman T, Jortso E, et al
    Age and tumour presentations differ between HPV type 16 positive and other high-risk HPV type-positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000-2022.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70087.
    >> Share

  63. ZHANG LT, Wu XY, Zhang HY, Li EM, et al
    Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.
    Int J Cancer. 2025 Aug 11. doi: 10.1002/ijc.70080.
    >> Share

    July 2025
  64. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis.
    Int J Cancer. 2025 Jul 30. doi: 10.1002/ijc.70033.
    >> Share

  65. YAN D, Wang L, Huang L, Cheng K, et al
    Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors.
    Int J Cancer. 2025 Jul 19. doi: 10.1002/ijc.70001.
    >> Share

  66. WANG J, Wang L, Wang T, Tang T, et al
    Eye-sparing treatment for sinonasal tumors invading the orbit in the era of personalized therapy.
    Int J Cancer. 2025;157:151-160.
    >> Share

    June 2025
  67. SONG XY, Lin L, Yang Y, Hu HH, et al
    Radiotherapy as an organ-preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy.
    Int J Cancer. 2025 Jun 25. doi: 10.1002/ijc.35515.
    >> Share

  68. MODESTO A, Gibert S, Delmas C, Tougeron D, et al
    Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.
    Int J Cancer. 2025 Jun 20. doi: 10.1002/ijc.70011.
    >> Share

  69. GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al
    Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
    Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491.
    >> Share

  70. CHAN WC, Millwood I, Kartsonaki C, Du H, et al
    Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of 0.5 million Chinese adults.
    Int J Cancer. 2025;156:2094-2106.
    >> Share

    May 2025
  71. LIN H, Ma J, Heng Y, Zhu X, et al
    CD8(+) T cells in patients with hypopharyngeal squamous cell carcinoma are susceptible to radiation-induced damage.
    Int J Cancer. 2025;156:2010-2023.
    >> Share

  72. YAN L, Lin Y, Lin W, Hong J, et al
    Treatment outcomes in nasopharyngeal carcinoma patients with parotid lymph node metastasis: An 11-year experience at a tertiary cancer center.
    Int J Cancer. 2025 May 7. doi: 10.1002/ijc.35470.
    >> Share

    March 2025
  73. LAN K, Liu S, Li S, Sun X, et al
    Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching.
    Int J Cancer. 2025 Mar 29. doi: 10.1002/ijc.35408.
    >> Share


  74. Correction to "Chronotherapy in head and neck cancer: A systematic review and meta-analysis".
    Int J Cancer. 2025 Mar 7. doi: 10.1002/ijc.35396.
    >> Share

    February 2025
  75. HU Y, Lu T, Zhang H, Chen B, et al
    Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study.
    Int J Cancer. 2025 Feb 24. doi: 10.1002/ijc.35382.
    >> Share

  76. WANG H, Fan T, Lu Y, Que L, et al
    Baseline audiometric assessment of newly diagnosed nasopharyngeal carcinoma patients: a multicentre cross-sectional study.
    Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35358.
    >> Share

    January 2025
  77. XIAO Z, Chen W, Du Y, Zeng F, et al
    Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single-arm clinical trial.
    Int J Cancer. 2025 Jan 18. doi: 10.1002/ijc.35340.
    >> Share

  78. POISSONNET V, Uro-Coste E, Chabrillac E, Modesto A, et al
    Malignant salivary gland tumors of the tongue: A multicenter REFCOR study.
    Int J Cancer. 2025;156:310-321.
    >> Share

  79. ZHAO R, Yuan H, Chen S, Xu K, et al
    Impact of accelerated biological aging and genetic variation on esophageal adenocarcinoma: Joint and interaction effect in a prospective cohort.
    Int J Cancer. 2025;156:299-309.
    >> Share

  80. SLOTMAN E, Pape M, van Laarhoven HWM, Pouw RE, et al
    Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.
    Int J Cancer. 2025 Jan 9. doi: 10.1002/ijc.35314.
    >> Share

    December 2024
  81. WANG J, Li B, Zhang Y, Luo X, et al
    Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35261.
    >> Share

  82. JHAWAR SR, Haring C, Pan X, Ma J, et al
    Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35291.
    >> Share

  83. NORONHA V, Patil VM, Menon N, Goud S, et al
    Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer.
    Int J Cancer. 2024;155:2232-2245.
    >> Share

  84. SEWASTJANOW-SILVA M, Kwiatkowski E, Yamashita K, Abdelhakeem A, et al
    Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.
    Int J Cancer. 2024;155:2277-2286.
    >> Share

  85. INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al
    One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study.
    Int J Cancer. 2024;155:1944-1957.
    >> Share

    November 2024
  86. JIN ZY, Liu K, Wallar G, Zhou JY, et al
    Environmental tobacco smoking (ETS) and esophageal cancer: A population-based case-control study in Jiangsu Province, China.
    Int J Cancer. 2024 Nov 18. doi: 10.1002/ijc.35254.
    >> Share

  87. ABUSAMAK M, Abu-Samak AA, Cai W, Al-Waeli H, et al
    Chronotherapy in head and neck cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35234.
    >> Share

  88. RUTKOWSKI TW, Kurczyk A, Drosik-Rutowicz K, Kiprian D, et al
    Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35248.
    >> Share

  89. KARIMI A, Mohebbi E, Mckay-Chopin S, Hadji M, et al
    Association of opium use and tobacco smoking with alpha-, beta-, and gamma-human papillomavirus oral infection.
    Int J Cancer. 2024;155:1544-1548.
    >> Share

  90. SCHEI-ANDERSEN AJ, Hendricks LAJ, van der Post RS, Mensenkamp AR, et al
    Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.
    Int J Cancer. 2024;155:1567-1576.
    >> Share

    October 2024

  91. RETRACTION: A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer.
    Int J Cancer. 2024 Oct 22. doi: 10.1002/ijc.35230.
    >> Share

  92. HSU WL, Tao J, Fu S, Yu KJ, et al
    Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.
    Int J Cancer. 2024;155:1400-1408.
    >> Share

  93. SHEN Y, You Z, Li L, Tang X, et al
    The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis.
    Int J Cancer. 2024;155:1290-1302.
    >> Share

  94. YAN X, Zeng H, Li H, Cao M, et al
    The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population-based cohort study.
    Int J Cancer. 2024;155:1203-1211.
    >> Share

    September 2024
  95. WANG W, Ye L, Li H, Chen W, et al
    A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions.
    Int J Cancer. 2024 Sep 14. doi: 10.1002/ijc.35153.
    >> Share

  96. PIRES C, Marques IJ, Saramago A, Moura MM, et al
    Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways.
    Int J Cancer. 2024 Sep 9. doi: 10.1002/ijc.35159.
    >> Share

  97. IWAKI S, Kawakita D, Nagao T, Tada Y, et al
    Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan.
    Int J Cancer. 2024;155:871-882.
    >> Share

    August 2024
  98. JANKE F, Stritzke F, Dvornikovich K, Franke H, et al
    Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
    Int J Cancer. 2024 Aug 30. doi: 10.1002/ijc.35152.
    >> Share

  99. SHI X, Lu M, Li X, Li J, et al
    The transcriptional landscape and clinico-biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma.
    Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35147.
    >> Share

  100. HUANG H, Zhao Y, Deng Y, Zhan Z, et al
    Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.
    Int J Cancer. 2024 Aug 26. doi: 10.1002/ijc.35139.
    >> Share

    July 2024
  101. WENG Z, Mai Z, Yuan J, Liu Q, et al
    Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy.
    Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35118.
    >> Share

  102. LAURITZEN BB, Gronlund MW, Jakobsen KK, Justesen MM, et al
    Epidemiological trends and survival of oropharyngeal cancer in a high HPV-prevalent area: A Danish population-based study from 2000 to 2020.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35099.
    >> Share

  103. WANG R, Chen XZ
    Comment on "Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study".
    Int J Cancer. 2024;155:184-185.
    >> Share

    June 2024
  104. MA L, Wang TM, He YQ, Liao Y, et al
    Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2024 Jun 18. doi: 10.1002/ijc.35061.
    >> Share

  105. SUN X, Lin X, Yao J, Tian T, et al
    Potential causal links of long-term exposure to PM(2.5) and its chemical components with the risk of nasopharyngeal carcinoma recurrence: A 10-year cohort study in South China.
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35047.
    >> Share

    May 2024
  106. GUO D, Jin J, Li D, He Y, et al
    Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan.
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35003.
    >> Share

  107. HUI Z, Wang B, Liu Z, Wei J, et al
    TGFbeta-induced EN1 promotes tumor budding of adenoid cystic carcinoma in patient-derived organoid model.
    Int J Cancer. 2024;154:1814-1827.
    >> Share

  108. KITAHARA CM, Surcel HM, Falk R, Pfeiffer RM, et al
    Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort.
    Int J Cancer. 2024 May 2. doi: 10.1002/ijc.34974.
    >> Share

  109. FANG F, Ritz B, Rao J, Zhu Y, et al
    Association between ambient exposure to PM(2.5) and upper aerodigestive tract cancer in Los Angeles.
    Int J Cancer. 2024;154:1579-1586.
    >> Share

    April 2024
  110. VASILIADOU I, Grose D, Wilson C, Thapa A, et al
    The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963.
    >> Share

  111. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    >> Share

  112. NAKAGAWA T, Santos J, Nasamran CA, Sen P, et al
    Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA-sequencing.
    Int J Cancer. 2024;154:1492-1503.
    >> Share

  113. DI W, Yu J, Zong D, Ge Y, et al
    Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
    Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
    >> Share

  114. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    >> Share

  115. LEE JH, Ming Z, Cheung VKY, Pedersen B, et al
    Ex vivo tissue modelling informs drug selection for rare cancers.
    Int J Cancer. 2024;154:1158-1163.
    >> Share

    March 2024
  116. CHARTERS E, Cheng K, Dunn M, Heng C, et al
    Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
    Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
    >> Share

  117. DOHERTY N, Cardwell C, Murchie P, Hill C, et al
    Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study.
    Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34937.
    >> Share

  118. MADRIGAL JM, Troisi R, Surcel HM, Ohman H, et al
    Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Int J Cancer. 2024;154:979-991.
    >> Share

  119. LU Y, Clifford GM, Fairley CK, Grulich AE, et al
    Human papillomavirus and p16(INK4a) in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2024;154:830-841.
    >> Share

    February 2024
  120. RINALDI S, Dossus L, Keski-Rahkonen P, Kiss A, et al
    Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
    Int J Cancer. 2024 Feb 15. doi: 10.1002/ijc.34872.
    >> Share

  121. SEYYEDSALEHI MS, Boffetta P
    Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34881.
    >> Share

  122. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34861.
    >> Share

    January 2024
  123. KAIMILA B, Yano Y, Mulima G, Chen Y, et al
    Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34829.
    >> Share

    November 2023
  124. STUART CM, Meguid RA, Bronsert MR, Rodriguez Franco S, et al
    The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.
    Int J Cancer. 2023 Nov 28. doi: 10.1002/ijc.34805.
    >> Share


  125. Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
    Int J Cancer. 2023 Nov 19. doi: 10.1002/ijc.34789.
    >> Share

  126. RANGEL-POZZO A, Dos Santos FF, Dettori T, Giulietti M, et al
    Three-dimensional nuclear architecture distinguishes thyroid cancer histotypes.
    Int J Cancer. 2023;153:1842-1853.
    >> Share

    October 2023
  127. DOCHI H, Kondo S, Komura S, Moriyama-Kita M, et al
    Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34777.
    >> Share

    September 2023
  128. RAN X, Zeng H, Zheng R, Sun K, et al
    Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population-based study.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34730.
    >> Share

  129. SCOBIOALA S, Parfitt R, Matulat P, Byrne J, et al
    The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34732.
    >> Share

  130. KUSTERS JMA, Diergaarde B, Ness A, Schim van der Loeff MF, et al
    Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34710.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016